|
1
|
Gupta S and Weitzman S: Primary and
secondary hemophagocytic lymphohistiocytosis: Clinical features,
pathogenesis and therapy. Expert Rev Clin Immunol. 6:137–154.
2010.PubMed/NCBI
|
|
2
|
Tang YM and Xu XJ: Advances in
hemophagocytic lymphohistiocytosis: Pathogenesis, early
diagnosis/differential diagnosis, and treatment.
ScientificWorldJournal. 11:697–708. 2011.PubMed/NCBI
|
|
3
|
Trottestam H, Horne A, Aricò M, Egeler RM,
Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, et
al: Chemoimmunotherapy for hemophagocytic lymphohistiocytosis:
Long-term results of the HLH-94 treatment protocol. Blood.
118:4577–4584. 2011.PubMed/NCBI
|
|
4
|
Henter JI, Horne A, Aricó M, Egeler RM,
Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski
J and Janka G: HLH-2004: Diagnostic and therapeutic guidelines for
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
48:124–131. 2007.PubMed/NCBI
|
|
5
|
Chandrakasan S and Filipovich AH:
Hemophagocytic lymphohistiocytosis: Advances in pathophysiology,
diagnosis, and treatment. J Pediatr. 163:1253–1259. 2013.PubMed/NCBI
|
|
6
|
Xu XJ, Tang YM, Song H, Yang SL, Xu WQ,
Zhao N, Shi SW, Shen HP, Mao JQ, Zhang LY and Pan BH: Diagnostic
accuracy of a specific cytokine pattern in hemophagocytic
lymphohistiocytosis in children. J Pediatr. 160:984–990.e1.
2012.PubMed/NCBI
|
|
7
|
Tsuji T, Hirano T, Yamasaki H, Tsuji M and
Tsuda H: A high sIL-2R/ferritin ratio is a useful marker for the
diagnosis of lymphoma-associated hemophagocytic syndrome. Ann
Hematol. 93:821–826. 2014.PubMed/NCBI
|
|
8
|
Allen CE, Yu X, Kozinetz CA and McClain
KL: Highly elevated ferritin levels and the diagnosis of
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
50:1227–1235. 2008.PubMed/NCBI
|
|
9
|
Tang Y, Liao C, Xu X, Song H, Shi S, Yang
S, Zhao F, Xu W, Chen X, Mao J, et al: Evaluation of Th1/Th2
cytokines as a rapid diagnostic tool for severe infection in
paediatric haematology/oncology patients by the use of cytometric
bead array technology. Clin Microbiol Infect. 17:1666–1673.
2011.PubMed/NCBI
|
|
10
|
Jordan MB, Hildeman D, Kappler J and
Marrack P: An animal model of hemophagocytic lymphohistiocytosis
(HLH): CD8+ T cells and interferon gamma are essential for the
disorder. Blood. 104:735–743. 2004.PubMed/NCBI
|
|
11
|
Pachlopnik Schmid J, Ho CH, Chrétien F,
Lefebvre JM, Pivert G, Kosco-Vilbois M, Ferlin W, Geissmann F,
Fischer A and de Saint Basile G: Neutralization of IFNgamma defeats
haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient
mice. EMBO Mol Med. 1:112–124. 2009.PubMed/NCBI
|
|
12
|
Weidong D, Xueling M and Schneider EM: A
direct immunoassay assessment of streptavidin- and
N-hydroxysuccinimide-modified biochips in validation of serological
TNFalpha responses in hemophagocytic lymphohistiocytosis. J Biomol
Screen. 13:515–526. 2008.PubMed/NCBI
|
|
13
|
Liu Q, Liu SS, Li SG, Gao Y, Ye L, Johnson
GOR, Song ZJ and Du WD: Establishment of a protein biochip to
detect serum IgG antibodies against IL-2 and soluble CD25 in
hemophagocytic lymphohistiocytosis. Clin Chim Acta. 487:256–263.
2018.PubMed/NCBI
|
|
14
|
Dupuy AM, Lehmann S and Cristol JP:
Protein biochip systems for the clinical laboratory. Clin Chem Lab
Med. 43:1291–1302. 2005.PubMed/NCBI
|
|
15
|
Moore CD, Ajala OZ and Zhu H: Applications
in high-content functional protein microarrays. Curr Opin Chem
Biol. 30:21–27. 2016.PubMed/NCBI
|
|
16
|
Liu RH, Dill K, Fuji HS and McShea A:
Integrated microfluidic biochips for DNA microarray analysis.
Expert Rev Mol Diagn. 6:253–261. 2006.PubMed/NCBI
|
|
17
|
Campos BB, Oliva MM, Contreras-Cáceres R,
Rodriguez-Castellón E, Jiménez-Jiménez J, da Silva JC and Algarra
M: Carbon dots on based folic acid coated with PAMAM dendrimer as
platform for Pt(IV) detection. J Colloid Interface Sci.
465:165–173. 2016.PubMed/NCBI
|
|
18
|
Müller M, Agarwal N and Kim J: A
cytochrome P450 3A4 biosensor based on generation 4.0 PAMAM
dendrimers for the detection of caffeine. Biosensors. 6:442016.
|
|
19
|
Jin H, Gui R, Gao X and Sun Y: An
amplified label-free electrochemical aptasensor of γ-interferon
based on target-induced DNA strand transform of hairpin-to-linear
conformation enabling simultaneous capture of redox probe and
target. Biosens Bioelectron. 145:1117322019.PubMed/NCBI
|
|
20
|
Ma K, Zhang F, Sayyadi N, Chen W, Anwer
AG, Care A, Xu B, Tian W, Goldys EM and Liu G: ‘Turn-on’
fluorescent aptasensor based on AIEgen labeling for the
localization of IFN-γ in live cells. ACS Sens. 3:320–326.
2018.PubMed/NCBI
|
|
21
|
Pavlickova P, Jensen NM, Paul H,
Schaeferling M, Giammasi C, Kruschina M, Du WD, Theisen M, Ibba M,
Ortigao F and Kambhampati D: Antibody detection in human serum
using a versatile protein chip platform constructed by applying
nanoscale self-assembled architectures on gold. J Proteome Res.
1:227–231. 2002.PubMed/NCBI
|
|
22
|
Chanphai P, Froehlich E, Mandeville JS and
Tajmir-Riahi HA: Protein conjugation with PAMAM nanoparticles:
Microscopic and thermodynamic analysis. Colloids Surf B
Biointerfaces. 150:168–174. 2017.PubMed/NCBI
|
|
23
|
Zhang Y, Wang F, Zhang H, Wang H and Liu
Y: Multivalency interface and g-C3N4 coated
liquid metal nanoprobe signal amplification for sensitive
electrogenerated chemiluminescence detection of exosomes and their
surface proteins. Anal Chem. 91:12100–12107. 2019.PubMed/NCBI
|
|
24
|
Zhang M, Ren Y, Wang Y, Wang R, Zhou Q,
Peng Y, Li Q, Yu M and Jiang Y: Regulation of smooth muscle
contractility by competing endogenous mRNAs in intracranial
aneurysms. J Neuropathol Exp Neurol. 74:411–424. 2015.PubMed/NCBI
|
|
25
|
Gandhiraman RP, Gubala V, Le NC, Volcke C,
Doyle C, James B, Daniels S and Williams DE: Deposition of
chemically reactive and repellent sites on biosensor chips for
reduced non-specific binding. Colloids Surf B Biointerfaces.
79:270–275. 2010.PubMed/NCBI
|
|
26
|
Ye L, Huang NL, Ma XL, Schneider M, Huang
XJ and Du WD: Establishment of N-succinimidyl 4-(maleimidomethyl)
cyclohexanecarboxylate (SMCC) modified biochip enabling concurrent
detection of serum infectious antibodies in neuroborreliosis.
Biosens Bioelectron. 78:404–410. 2016.PubMed/NCBI
|
|
27
|
Otrock ZK, Hock KG, Riley SB, de Witte T,
Eby CS and Scott MG: Elevated serum ferritin is not specific for
hemophagocytic lymphohistiocytosis. Ann Hematol. 96:1667–1672.
2017.PubMed/NCBI
|
|
28
|
Kurzrock R, Rohde MF, Quesada JR,
Gianturco SH, Bradley WA, Sherwin SA and Gutterman JU: Recombinant
gamma interferon induces hypertriglyceridemia and inhibits
post-heparin lipase activity in cancer patients. J Exp Med.
164:1093–1101. 1986.PubMed/NCBI
|
|
29
|
Lin A, Ma TP, Cheng FW and Ng PC: Neonatal
haemophagocytic lymphohistiocytosis associated with maternal
adult-onset still's disease. Neonatology. 110:267–269.
2016.PubMed/NCBI
|
|
30
|
Oaks M, Taylor S and Shaffer J:
Autoantibodies targeting tumor-associated antigens in metastatic
cancer: Sialylated IgGs as candidate anti-inflammatory antibodies.
Oncoimmunology. 2:e248412013.PubMed/NCBI
|
|
31
|
Lovisari F, Terzi V, Lippi MG, Brioschi PR
and Fumagalli R: Hemophagocytic lymphohistiocytosis complicated by
multiorgan failure: A case report. Medicine (Baltimore).
96:e91982017.PubMed/NCBI
|
|
32
|
Avau A and Matthys P: Therapeutic
potential of interferon-γ and its antagonists in autoinflammation:
Lessons from murine models of systemic juvenile idiopathic
arthritis and macrophage activation syndrome. Pharmaceuticals
(Basel). 8:793–815. 2015.PubMed/NCBI
|
|
33
|
Prencipe G, Caiello I, Pascarella A, Grom
AA, Bracaglia C, Chatel L, Ferlin WG, Marasco E, Strippoli R, de
Min C and De Benedetti F: Neutralization of IFN-γ reverts clinical
and laboratory features in a mouse model of macrophage activation
syndrome. J Allergy Clin Immunol. 141:1439–1449. 2018.PubMed/NCBI
|
